<DOC>
	<DOC>NCT00839293</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.</brief_summary>
	<brief_title>Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules</brief_title>
	<detailed_description />
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>A condition of general good health BMI 18 to 29 Currently enrolled in another clinical study Females who are pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Bioavailability</keyword>
</DOC>